Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

BACKGROUND: Neonates born to women infected with HIV are at increased risk for invasive group B streptococcus (GBS) disease. We aimed to compare safety and immunogenicity of trivalent glycoconjugate GBS vaccine in pregnant women with and without HIV in Malawi and South Africa. METHODS: In our non-ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyderman, Robert S, Madhi, Shabir A, French, Neil, Cutland, Clare, Ngwira, Bagrey, Kayambo, Doris, Mboizi, Robert, Koen, Anthonet, Jose, Lisa, Olugbosi, Morounfolu, Wittke, Frederik, Slobod, Karen, Dull, Peter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835545/
https://www.ncbi.nlm.nih.gov/pubmed/26869376
http://dx.doi.org/10.1016/S1473-3099(15)00484-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835545/
https://www.ncbi.nlm.nih.gov/pubmed/26869376
http://dx.doi.org/10.1016/S1473-3099(15)00484-3

Ejemplares similares